GT Biopharma Announces $16 million in Warrant Exercise Proceeds
Proceeds to Support GTBP Pipeline Drug Development Program BEVERLY HILLS, Calif., July 28, 2021 /PRNewswire/ — GT Biopharma, Inc. (NASDAQ: GTBP), an immuno-oncology company focused on innovative therapies based on